Literature DB >> 18262379

Primary resistance to antituberculosis drugs: trends in Cote d'Ivoire from 1995 to 2006.

K N'guessan, M Dosso, I Nahoua, M San Koffi, J Kouakou.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18262379     DOI： 10.1016/j.medmal.2007.11.004

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN： 0399-077X            Impact factor:   2.152


× No keyword cloud information.
  5 in total

1.  Assessment of the genotype MTBDRplus assay for rifampin and isoniazid resistance detection on sputum samples in Cote d'Ivoire.

Authors:  K N'guessan; J S Assi; T Ouassa; J M Ahui-Brou; A Tehe; M Keita Sow; A Guei; J Kouakou; M Dosso
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-09-11

Review 2.  Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Deus Lukoye; Willy Ssengooba; Kenneth Musisi; George W Kasule; Frank G J Cobelens; Moses Joloba; Gabriela B Gomez
Journal:  BMC Public Health       Date:  2015-03-25       Impact factor: 3.295

Review 3.  Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.

Authors:  Baba Maiyaki Musa; Aishatu L Adamu; Najibah A Galadanci; Bashir Zubayr; Chisom N Odoh; Muktar H Aliyu
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

Review 4.  Emergence in Western African countries of MDR-TB, focus on Côte d'Ivoire.

Authors:  Euloge Ekaza; Raymond Kouassi N'Guessan; Adèle Kacou-N'Douba; N'Guetta Aka; Jacquemin Kouakou; Françoise Le Vacon; Fréderic Altare; Gilles Potel; Marie-France de-La-Cochetiere
Journal:  Biomed Res Int       Date:  2013-09-04       Impact factor: 3.411

5.  Multidrug-Resistant Tuberculosis in Côte d'Ivoire from 1995 to 2016: Results of National Surveys.

Authors:  Kouassi N'Guessan; Timothée Ouassa; Anna S Dean; Riccardo Alagna; Guy Damien Adagra; Valeri Ibode; Daniela M Cirillo; Jacquemin Kouakou
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2018-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.